The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.d

Lupus - Lupus syndrome (see also Vd)

Publications

Schoonen WM, Thomas SL, Somers EC, Smeeth L, Kim J, Evans S, Hall AJ

Do selected drugs increase the risk of lupus? A matched case-control study.

British journal of clinical pharmacology. 2010;70(4):588-96

Motta E, Kazibutowska Z, Lorek A, Januszewski K, Gołba A, Wianecka A

[Carbamazepine-induced systemic lupus erythematosus--a case report].

Neurologia i neurochirurgia polska. 2006;40(2):151-5

Wittchen F, Spencker S, Zinke S, Coban N, Schultheiss HP, Witzenbichler B

[Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication].

Der Internist. 2006;47(1):69-75

Milesi-Lecat AM, Schmidt J, Aumaitre O, Kemeny JL, Moinard J, Piette JC

Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine.

Mayo Clinic proceedings. 1997;72(12):1145-7

Alballa S, Fritzler M, Davis P

A case of drug induced lupus due to carbamazepine.

The Journal of rheumatology. 1987;14(3):599-600